$BPMC Blueprint Medicines Corp Insider Trading
Get free email notifications about insider trading in Blueprint Medicines Corp.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in Blueprint Medicines Corp. Insider overview, share value development, latest insider transactions and email notifications about new events in Blueprint Medicines Corp for free.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Trading Symbol: BPMC
Company Address: 45 SIDNEY STREET CAMBRIDGE 02139
Phone number: 617-374-7580
Blueprint Medicines Corp. is a precision therapy company. It focuses on medicines to improve the lives of patients with genomically defined cancers, rare diseases, blood disorders, and cancer immunotherapy. The company was founded by Chris Varma, Nicholas B. Lydon, Brian Druker, and Alexis Borisy on October 14, 2008 and is headquartered in Cambridge, MA.
Market Capitalization: $979.55M
Prev close: $35.84
Average Daily Volume: 372,323
Days Low: $35.11
Year Low: $13.26
Year High: $38.33
Blueprint Medicines Corp Latest Insider Transactions
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| May 14 2021 | BPMC | Blueprint Medicine ... | Albers Jeffrey W. | CEO and President | Option Exercise | M | 1.87 | 7,500 | 14,025 | 166,403 | |
| May 14 2021 | BPMC | Blueprint Medicine ... | Albers Jeffrey W. | CEO and President | Option Exercise | M | 15.01 | 17,500 | 262,675 | 122,500 | |
| May 14 2021 | BPMC | Blueprint Medicine ... | Albers Jeffrey W. | CEO and President | Sell | S | 91.89 | 2,953 | 271,351 | 172,448 | 175.4 K to 172.4 K (-1.68 %) |
| May 14 2021 | BPMC | Blueprint Medicine ... | Albers Jeffrey W. | CEO and President | Sell | S | 92.62 | 16,383 | 1,517,393 | 175,401 | 191.8 K to 175.4 K (-8.54 %) |
| May 14 2021 | BPMC | Blueprint Medicine ... | Albers Jeffrey W. | CEO and President | Sell | S | 93.33 | 5,664 | 528,621 | 191,784 | 197.4 K to 191.8 K (-2.87 %) |
| May 14 2021 | BPMC | Blueprint Medicine ... | Albers Jeffrey W. | CEO and President | Buy | M | 15.01 | 17,500 | 262,675 | 197,448 | 179.9 K to 197.4 K (+9.73 %) |
| May 14 2021 | BPMC | Blueprint Medicine ... | Albers Jeffrey W. | CEO and President | Buy | M | 1.87 | 7,500 | 14,025 | 179,948 | 172.4 K to 179.9 K (+4.35 %) |
| Mar 17 2021 | BPMC | Blueprint Medicine ... | Haviland Kate | Chief Operating Off ... | Option Exercise | M | 36.05 | 1,000 | 36,050 | 3,591 | |
| Mar 17 2021 | BPMC | Blueprint Medicine ... | Haviland Kate | Chief Operating Off ... | Sell | S | 104.65 | 322 | 33,697 | 53,948 | 54.3 K to 53.9 K (-0.59 %) |
| Mar 17 2021 | BPMC | Blueprint Medicine ... | Haviland Kate | Chief Operating Off ... | Sell | S | 105.44 | 426 | 44,917 | 54,270 | 54.7 K to 54.3 K (-0.78 %) |
| Mar 17 2021 | BPMC | Blueprint Medicine ... | Haviland Kate | Chief Operating Off ... | Sell | S | 106.62 | 108 | 11,515 | 54,696 | 54.8 K to 54.7 K (-0.20 %) |
| Mar 17 2021 | BPMC | Blueprint Medicine ... | Haviland Kate | Chief Operating Off ... | Sell | S | 107.42 | 138 | 14,824 | 54,804 | 54.9 K to 54.8 K (-0.25 %) |
| Mar 17 2021 | BPMC | Blueprint Medicine ... | Haviland Kate | Chief Operating Off ... | Sell | S | 108.16 | 6 | 649 | 54,942 | 54.9 K to 54.9 K (-0.01 %) |
| Mar 17 2021 | BPMC | Blueprint Medicine ... | Haviland Kate | Chief Operating Off ... | Buy | M | 36.05 | 1,000 | 36,050 | 54,948 | 53.9 K to 54.9 K (+1.85 %) |
| Mar 17 2021 | BPMC | Blueprint Medicine ... | Haviland Kate | Chief Operating Off ... | Option Exercise | M | 36.05 | 1,000 | 36,050 | 3,591 |